| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CDP phosphatase activity | 1.04e-04 | 4 | 84 | 2 | GO:0036384 | |
| GeneOntologyMolecularFunction | IDP phosphatase activity | 1.73e-04 | 5 | 84 | 2 | GO:1990003 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 2.06e-04 | 599 | 84 | 10 | GO:0050839 | |
| GeneOntologyMolecularFunction | ADP phosphatase activity | 3.62e-04 | 7 | 84 | 2 | GO:0043262 | |
| GeneOntologyMolecularFunction | UDP phosphatase activity | 6.18e-04 | 9 | 84 | 2 | GO:0045134 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | DPP6 BMPR1B NEO1 OLFM3 KCNJ16 OLFM1 ABCC9 OLFM2 NCSTN ITGAE CDH6 CDH10 | 8.63e-05 | 785 | 86 | 12 | GO:0098797 |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic membrane | 9.78e-05 | 22 | 86 | 3 | GO:0098890 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 2.52e-04 | 30 | 86 | 3 | GO:0032281 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 2.56e-04 | 137 | 86 | 5 | GO:0019897 | |
| GeneOntologyCellularComponent | membrane protein complex | SEL1L DPP6 BMPR1B NEO1 OLFM3 KCNJ16 VAMP7 OLFM1 ABCC9 OLFM2 NCSTN ITGAE CDH6 CDH10 DDOST NDUFV3 | 3.59e-04 | 1498 | 86 | 16 | GO:0098796 |
| GeneOntologyCellularComponent | extrinsic component of synaptic membrane | 4.00e-04 | 35 | 86 | 3 | GO:0099243 | |
| GeneOntologyCellularComponent | azurophil granule | 5.22e-04 | 160 | 86 | 5 | GO:0042582 | |
| GeneOntologyCellularComponent | primary lysosome | 5.22e-04 | 160 | 86 | 5 | GO:0005766 | |
| GeneOntologyCellularComponent | synaptic membrane | 6.55e-04 | 583 | 86 | 9 | GO:0097060 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic density membrane | 7.37e-04 | 10 | 86 | 2 | GO:0099147 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 8.42e-04 | 45 | 86 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic specialization membrane | 1.07e-03 | 12 | 86 | 2 | GO:0098892 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 1.15e-03 | 50 | 86 | 3 | GO:0098878 | |
| GeneOntologyCellularComponent | azurophil granule membrane | 1.85e-03 | 59 | 86 | 3 | GO:0035577 | |
| Domain | Noelin-1 | 9.10e-08 | 3 | 85 | 3 | PF12308 | |
| Domain | Noelin_dom | 9.10e-08 | 3 | 85 | 3 | IPR022082 | |
| Domain | OLF | 2.77e-07 | 13 | 85 | 4 | PS51132 | |
| Domain | Olfac-like_dom | 2.77e-07 | 13 | 85 | 4 | IPR003112 | |
| Domain | OLF | 2.77e-07 | 13 | 85 | 4 | SM00284 | |
| Domain | OLF | 2.77e-07 | 13 | 85 | 4 | PF02191 | |
| Domain | Quino_amine_DH_bsu | 1.32e-04 | 22 | 85 | 3 | IPR011044 | |
| Domain | ANK | 1.47e-04 | 251 | 85 | 7 | SM00248 | |
| Domain | ANK_REPEAT | 1.55e-04 | 253 | 85 | 7 | PS50088 | |
| Domain | ANK_REP_REGION | 1.59e-04 | 254 | 85 | 7 | PS50297 | |
| Domain | Ankyrin_rpt | 1.92e-04 | 262 | 85 | 7 | IPR002110 | |
| Domain | GPCR_2_latrophilin | 2.03e-04 | 5 | 85 | 2 | IPR003924 | |
| Domain | Sel1 | 5.63e-04 | 8 | 85 | 2 | PF08238 | |
| Domain | SEL1 | 5.63e-04 | 8 | 85 | 2 | SM00671 | |
| Domain | GDA1_CD39_NTPase | 5.63e-04 | 8 | 85 | 2 | IPR000407 | |
| Domain | GDA1_CD39 | 5.63e-04 | 8 | 85 | 2 | PF01150 | |
| Domain | GDA1_CD39_NTPASE | 5.63e-04 | 8 | 85 | 2 | PS01238 | |
| Domain | Ank | 6.07e-04 | 228 | 85 | 6 | PF00023 | |
| Domain | TPR-like_helical_dom | 6.80e-04 | 233 | 85 | 6 | IPR011990 | |
| Domain | Sel1-like | 7.22e-04 | 9 | 85 | 2 | IPR006597 | |
| Domain | Ankyrin_rpt-contain_dom | 1.06e-03 | 254 | 85 | 6 | IPR020683 | |
| Domain | ER_TARGET | 1.28e-03 | 47 | 85 | 3 | PS00014 | |
| Domain | - | 2.55e-03 | 207 | 85 | 5 | 1.25.40.10 | |
| Domain | ALPHA_CA_2 | 2.66e-03 | 17 | 85 | 2 | PS51144 | |
| Domain | Carb_anhydrase | 2.66e-03 | 17 | 85 | 2 | PF00194 | |
| Domain | Carb_anhydrase | 2.66e-03 | 17 | 85 | 2 | SM01057 | |
| Domain | - | 2.66e-03 | 17 | 85 | 2 | 3.10.200.10 | |
| Domain | Carbonic_anhydrase_a | 2.66e-03 | 17 | 85 | 2 | IPR001148 | |
| Domain | Ank_2 | 3.00e-03 | 215 | 85 | 5 | PF12796 | |
| Domain | - | 5.49e-03 | 248 | 85 | 5 | 1.25.40.20 | |
| Domain | Cadherin_cytoplasmic-dom | 5.74e-03 | 25 | 85 | 2 | IPR000233 | |
| Domain | Cadherin_C | 5.74e-03 | 25 | 85 | 2 | PF01049 | |
| Domain | fn3 | 6.41e-03 | 162 | 85 | 4 | PF00041 | |
| Pubmed | 1.57e-08 | 3 | 88 | 3 | 21228389 | ||
| Pubmed | 3.11e-07 | 6 | 88 | 3 | 37591201 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SCO2 APPBP2 PI4KA SRP68 PCARE ANKRD18A HRNR AMOTL2 ITGAE CNOT1 DDOST RAI1 | 3.49e-07 | 736 | 88 | 12 | 29676528 |
| Pubmed | SEL1L DNAAF5 BPTF AARS1 HSP90B1 CDC123 FKBP9 OLFM1 SRP68 PSMD13 NCSTN CTSB CNOT1 GNS DDOST | 8.54e-07 | 1297 | 88 | 15 | 33545068 | |
| Pubmed | 8.69e-07 | 8 | 88 | 3 | 12475935 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SEL1L DNAAF5 SCO2 AARS1 IGF2BP2 TRIM26 IFT172 ANKRD28 CHD1 PSMD13 NCSTN ESPL1 DDOST | 1.04e-06 | 974 | 88 | 13 | 28675297 |
| Pubmed | 1.06e-06 | 71 | 88 | 5 | 12754519 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | BPTF HSP90B1 IGF2BP2 LIPA TCERG1 INTS11 RBM14 SRP68 SMARCE1 HRNR CNOT1 GNS DDOST | 3.30e-06 | 1082 | 88 | 13 | 38697112 |
| Pubmed | Identification of a region within SEL1L protein required for tumour growth inhibition. | 6.33e-06 | 2 | 88 | 2 | 14729273 | |
| Pubmed | Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors. | 6.33e-06 | 2 | 88 | 2 | 30006565 | |
| Pubmed | Molecular Details of Olfactomedin Domains Provide Pathway to Structure-Function Studies. | 6.33e-06 | 2 | 88 | 2 | 26121352 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 36792124 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 1.00e-05 | 411 | 88 | 8 | 35182466 | |
| Pubmed | 1.13e-05 | 197 | 88 | 6 | 31620119 | ||
| Pubmed | Cadherins Interact With Synaptic Organizers to Promote Synaptic Differentiation. | 1.90e-05 | 3 | 88 | 2 | 29760652 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 26087013 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 36263704 | ||
| Pubmed | 1.94e-05 | 325 | 88 | 7 | 36168628 | ||
| Pubmed | 2.57e-05 | 228 | 88 | 6 | 30471916 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | SEL1L DNAAF5 SCO2 AARS1 PI4KA VAMP7 SRP68 NCSTN ESPL1 DDOST NDUFV3 | 2.60e-05 | 942 | 88 | 11 | 31073040 |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 2.77e-05 | 231 | 88 | 6 | 36597993 | |
| Pubmed | 3.05e-05 | 24 | 88 | 3 | 22632720 | ||
| Pubmed | 3.15e-05 | 142 | 88 | 5 | 30232004 | ||
| Pubmed | 3.50e-05 | 638 | 88 | 9 | 33239621 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 28957665 | ||
| Pubmed | 3.79e-05 | 4 | 88 | 2 | 30197236 | ||
| Pubmed | 4.39e-05 | 657 | 88 | 9 | 36180527 | ||
| Pubmed | 4.73e-05 | 78 | 88 | 4 | 28611094 | ||
| Pubmed | 5.01e-05 | 257 | 88 | 6 | 16335952 | ||
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | 5.06e-05 | 516 | 88 | 8 | 36610398 | |
| Pubmed | Proteomic analysis of early melanosomes: identification of novel melanosomal proteins. | 5.45e-05 | 29 | 88 | 3 | 12643545 | |
| Pubmed | OS-9 facilitates turnover of nonnative GRP94 marked by hyperglycosylation. | 6.30e-05 | 5 | 88 | 2 | 24899641 | |
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 27539848 | ||
| Pubmed | 6.30e-05 | 5 | 88 | 2 | 27997605 | ||
| Pubmed | The meiosis I-to-meiosis II transition in mouse oocytes requires separase activity. | 6.30e-05 | 5 | 88 | 2 | 14561405 | |
| Pubmed | SEL1L DNAAF5 SCO2 HSP90B1 IGF2BP2 VAMP7 RBM14 ANKRD28 PSMD13 CTSB CNOT1 GNS DDOST | 6.64e-05 | 1440 | 88 | 13 | 30833792 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | SEL1L SCO2 AARS1 HSP90B1 NEO1 IGF2BP2 TCERG1 FKBP9 SRP68 SMARCE1 CTSB DDOST NDUFV3 | 7.17e-05 | 1451 | 88 | 13 | 30550785 |
| Pubmed | 9.43e-05 | 6 | 88 | 2 | 17171436 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | 1.02e-04 | 571 | 88 | 8 | 37167062 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DNAAF5 AARS1 PTPRG IFT172 RAB3IP VAMP7 RBM14 SRP68 ANKRD28 PCARE PSMD13 CNOT1 | 1.23e-04 | 1321 | 88 | 12 | 27173435 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 1.32e-04 | 759 | 88 | 9 | 35915203 | |
| Pubmed | Characterization of cadherins expressed by murine thymocytes. | 1.32e-04 | 7 | 88 | 2 | 8620560 | |
| Pubmed | 1.32e-04 | 7 | 88 | 2 | 8879495 | ||
| Pubmed | Presenilin 1 is required for maturation and cell surface accumulation of nicastrin. | 1.32e-04 | 7 | 88 | 2 | 11943765 | |
| Pubmed | 1.34e-04 | 39 | 88 | 3 | 24095980 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | AARS1 HSP90B1 IGF2BP2 TCERG1 PI4KA INTS11 RBM14 SRP68 ANKRD28 CHD1 PSMD13 DDOST | 1.53e-04 | 1353 | 88 | 12 | 29467282 |
| Pubmed | HSP90B1 IGF2BP2 TRIM26 RBM14 SRP68 SMARCE1 CHD1 PSMD13 NCSTN POTEJ HRNR | 1.57e-04 | 1153 | 88 | 11 | 29845934 | |
| Pubmed | 1.66e-04 | 613 | 88 | 8 | 22268729 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.71e-04 | 203 | 88 | 5 | 22083510 | |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 1.74e-04 | 109 | 88 | 4 | 33554859 | |
| Pubmed | 1.75e-04 | 8 | 88 | 2 | 18264092 | ||
| Pubmed | Purification and characterization of the human gamma-secretase complex. | 1.75e-04 | 8 | 88 | 2 | 15274632 | |
| Pubmed | 2.09e-04 | 634 | 88 | 8 | 34591612 | ||
| Pubmed | Characterization of LGALS3 (galectin-3) as a player in DNA damage response. | 2.20e-04 | 46 | 88 | 3 | 24755837 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SEL1L B3GALNT1 HSP90B1 FKBP9 OLFM1 SMARCE1 NCSTN PRSS23 SEZ6L2 GNS DDOST | 2.24e-04 | 1201 | 88 | 11 | 35696571 |
| Pubmed | 2.25e-04 | 9 | 88 | 2 | 22923468 | ||
| Pubmed | A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. | 2.25e-04 | 9 | 88 | 2 | 16728976 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | AARS1 HSP90B1 TCERG1 PI4KA INTS11 RBM14 SRP68 SMARCE1 CHD1 PSMD13 CNOT1 DDOST | 2.47e-04 | 1425 | 88 | 12 | 30948266 |
| Pubmed | 2.54e-04 | 653 | 88 | 8 | 22586326 | ||
| Pubmed | 2.63e-04 | 494 | 88 | 7 | 26831064 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.74e-04 | 351 | 88 | 6 | 38297188 | |
| Pubmed | Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. | 2.81e-04 | 10 | 88 | 2 | 2059658 | |
| Pubmed | 2.81e-04 | 10 | 88 | 2 | 10861224 | ||
| Pubmed | GINS complex protein Sld5 recruits SIK1 to activate MCM helicase during DNA replication. | 2.81e-04 | 10 | 88 | 2 | 27592030 | |
| Pubmed | 2.81e-04 | 10 | 88 | 2 | 22095909 | ||
| Pubmed | 2.97e-04 | 847 | 88 | 9 | 35850772 | ||
| Pubmed | HSP90B1 IGF2BP2 PTPRG PI4KA INTS11 ANKRD28 PSMD13 AJUBA CNOT1 DDOST | 3.21e-04 | 1049 | 88 | 10 | 27880917 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HSP90B1 IGF2BP2 TCERG1 TRIM26 RBM14 SRP68 PSMD13 PRSS23 HRNR AJUBA DDOST | 3.30e-04 | 1257 | 88 | 11 | 36526897 |
| Pubmed | 3.94e-04 | 56 | 88 | 3 | 30022168 | ||
| Pubmed | 4.11e-04 | 12 | 88 | 2 | 22102170 | ||
| Pubmed | Inhibition of N-glycan processing modulates the network of EDEM3 interactors. | 4.15e-04 | 57 | 88 | 3 | 28366632 | |
| Pubmed | 4.32e-04 | 707 | 88 | 8 | 19738201 | ||
| Pubmed | PRR12 BPTF AARS1 IGF2BP2 TCERG1 RBM14 SRP68 SMARCE1 CNOT1 RAI1 | 4.76e-04 | 1103 | 88 | 10 | 34189442 | |
| Pubmed | 4.85e-04 | 13 | 88 | 2 | 21929743 | ||
| Pubmed | 4.85e-04 | 13 | 88 | 2 | 18326817 | ||
| Pubmed | Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex. | 4.85e-04 | 13 | 88 | 2 | 11726552 | |
| Pubmed | 4.85e-04 | 13 | 88 | 2 | 25218043 | ||
| Pubmed | 5.04e-04 | 257 | 88 | 5 | 30945288 | ||
| Pubmed | 5.65e-04 | 14 | 88 | 2 | 8605874 | ||
| Pubmed | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. | 5.71e-04 | 149 | 88 | 4 | 25231870 | |
| Pubmed | 6.06e-04 | 408 | 88 | 6 | 33766124 | ||
| Pubmed | 6.51e-04 | 15 | 88 | 2 | 33833667 | ||
| Pubmed | Trio controls the mature organization of neuronal clusters in the hindbrain. | 6.51e-04 | 15 | 88 | 2 | 17898204 | |
| Pubmed | 6.51e-04 | 15 | 88 | 2 | 21857022 | ||
| Pubmed | 6.78e-04 | 156 | 88 | 4 | 29961565 | ||
| Pubmed | 6.97e-04 | 68 | 88 | 3 | 22779921 | ||
| Pubmed | Cadherin expression in the developing mouse olfactory system. | 7.42e-04 | 16 | 88 | 2 | 17278136 | |
| Pubmed | Genome-wide association study of recurrent early-onset major depressive disorder. | 7.42e-04 | 16 | 88 | 2 | 20125088 | |
| Pubmed | 7.80e-04 | 162 | 88 | 4 | 25796446 | ||
| Pubmed | 8.17e-04 | 164 | 88 | 4 | 32409323 | ||
| Pubmed | 8.40e-04 | 17 | 88 | 2 | 19741467 | ||
| Pubmed | 8.40e-04 | 17 | 88 | 2 | 19502414 | ||
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 8.54e-04 | 166 | 88 | 4 | 35687106 | |
| Pubmed | 8.61e-04 | 786 | 88 | 8 | 29128334 | ||
| Pubmed | 8.75e-04 | 985 | 88 | 9 | 12975309 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 8.76e-04 | 605 | 88 | 7 | 28977666 | |
| Pubmed | PRR12 BPTF IGF2BP2 TCERG1 SRP68 ANKRD28 SMARCE1 PSMD13 HRNR CNOT1 DDOST | 9.55e-04 | 1429 | 88 | 11 | 35140242 | |
| Pubmed | 1.05e-03 | 19 | 88 | 2 | 20161779 | ||
| Pubmed | Clinical risk factors, DNA variants, and the development of type 2 diabetes. | 1.05e-03 | 19 | 88 | 2 | 19020324 | |
| Pubmed | EDEM3 Domains Cooperate to Perform Its Overall Cell Functioning. | 1.05e-03 | 19 | 88 | 2 | 33671632 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 7.46e-06 | 13 | 55 | 3 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | 9.05e-05 | 242 | 55 | 6 | 403 | |
| GeneFamily | CD molecules|Type II classical cadherins | 6.94e-04 | 13 | 55 | 2 | 1186 | |
| GeneFamily | Fibronectin type III domain containing | 1.42e-03 | 160 | 55 | 4 | 555 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | NEO1 IGF2BP2 GLDN ABL1 PTPRG CST9L FKBP9 SMARCE1 C1QTNF7 CPED1 CDH6 CDH10 FREM1 | 2.39e-05 | 827 | 85 | 13 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 3.06e-05 | 398 | 85 | 9 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 4.48e-05 | 418 | 85 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#1_top-relative-expression-ranked_500 | 8.03e-05 | 110 | 85 | 5 | gudmap_developingKidney_e15.5_Podocyte cells_500_k1 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-MALT_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 2.13e-06 | 190 | 88 | 6 | 1f907016980ccfbf089e354d91d931771e8a83e0 | |
| ToppCell | severe-Plasmablast|World / disease stage, cell group and cell class | 2.40e-06 | 194 | 88 | 6 | 49e8f90db571a89b8a26aef31fcacd66429fed11 | |
| ToppCell | (2)_B_cells-(2)_Plasma_cells|(2)_B_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.55e-06 | 196 | 88 | 6 | cc4f59b885d58e43471e85c51d8e366e68d10846 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.17e-05 | 149 | 88 | 5 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | Basal_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.80e-05 | 163 | 88 | 5 | 679e25e5548d157d49a73057a3b5617dccda260f | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue-Endometrium|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.21e-05 | 170 | 88 | 5 | cdc19013da7c41d1ed8400a6a643e4c684ff9912 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.21e-05 | 170 | 88 | 5 | 0bde0a40440c7fdf7ba89cac8831d4014e7a4807 | |
| ToppCell | TCGA-Endometrium-Solid_Tissue_Normal-Endometrium_normal_tissue|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.21e-05 | 170 | 88 | 5 | 516b38c4ecf6b0b04c5d4f80c510dcc00b328c6f | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-05 | 171 | 88 | 5 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 172 | 88 | 5 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.47e-05 | 174 | 88 | 5 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 174 | 88 | 5 | dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89 | |
| ToppCell | wk_08-11-Epithelial-PNS-FGFBP2+_Neural_progenitor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.68e-05 | 177 | 88 | 5 | 15a5c96ea840376e54933ebe7a8334a11d9ce411 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.68e-05 | 177 | 88 | 5 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.83e-05 | 179 | 88 | 5 | 98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.90e-05 | 180 | 88 | 5 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.90e-05 | 180 | 88 | 5 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.98e-05 | 181 | 88 | 5 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.06e-05 | 182 | 88 | 5 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.22e-05 | 184 | 88 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-05 | 185 | 88 | 5 | 35d39a1d04c871edcfb749653538dc5fd0054281 | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 3.40e-05 | 186 | 88 | 5 | f4d72463c5f287da6436287eda0a349b4185841e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 3.57e-05 | 188 | 88 | 5 | c7b1807c96f87fbcd37739a159cf00f9a1ff5d71 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 188 | 88 | 5 | 9db778c1d9e622a68337212296e3a1ed8f771fa5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 188 | 88 | 5 | 047c4e0b03fc8334e38c48977e41d26dbe229d47 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 189 | 88 | 5 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 189 | 88 | 5 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 189 | 88 | 5 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | Striatum-Endothelial|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.66e-05 | 189 | 88 | 5 | 95ee3b6d7fbbfcf91c780dfcd0926acec05f0a2d | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 3.76e-05 | 190 | 88 | 5 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.76e-05 | 190 | 88 | 5 | 84eb7761f537d270673909a71d4f122e826769d5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.76e-05 | 190 | 88 | 5 | f85cdd79eefd699ada7a91bf4997cc730a9b9846 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 3.85e-05 | 191 | 88 | 5 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.85e-05 | 191 | 88 | 5 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.85e-05 | 191 | 88 | 5 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.95e-05 | 192 | 88 | 5 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | COVID-19_Severe-Lymphoid_P|COVID-19_Severe / Disease group, lineage and cell class | 3.95e-05 | 192 | 88 | 5 | 3d0240491296757b3125f6e861bbaca06bbc5068 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.95e-05 | 192 | 88 | 5 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | COVID-19_Severe-Lymphoid_P-Plasmablast|COVID-19_Severe / Disease group, lineage and cell class | 3.95e-05 | 192 | 88 | 5 | 90af8dad4e6f80b5ecd62027deeb2e4cea6b24bb | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 192 | 88 | 5 | 6417468829517a0f6e04e7e44eec1622001d4c5c | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.05e-05 | 193 | 88 | 5 | 6b3a2a32ec6dc96230cee4bbf03932f8a81e6683 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.05e-05 | 193 | 88 | 5 | b18c61e360f5f094f260007a56b189e2a48369e4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.05e-05 | 193 | 88 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | COVID-19_Severe-Plasmablast|COVID-19_Severe / disease group, cell group and cell class | 4.05e-05 | 193 | 88 | 5 | 8074bcede261b85f9ae03ee372bd6d4b40384537 | |
| ToppCell | PND07-28-samps-Mesenchymal|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.15e-05 | 194 | 88 | 5 | 68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 4.15e-05 | 194 | 88 | 5 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.15e-05 | 194 | 88 | 5 | 1ca034f25a8fce503fb67654d7fa2a8ec71976be | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-05 | 195 | 88 | 5 | cbe518b465b4ef32797ae6b608219207c08493df | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-05 | 195 | 88 | 5 | 136b06b0931a69b1241101f68c01c44c70365fd9 | |
| ToppCell | severe-Plasmablast|severe / disease stage, cell group and cell class | 4.25e-05 | 195 | 88 | 5 | e11616ad568e50e4c720b50b0c071f484c31d16b | |
| ToppCell | Mild/Remission-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.25e-05 | 195 | 88 | 5 | 52bdd609253613b7db75dccbc1c01c05e8d73f79 | |
| ToppCell | (6)_Macrophage-(61)_LYVE1_Macrophage|(6)_Macrophage / shred on Cell_type and subtype | 4.29e-05 | 98 | 88 | 4 | 30a9a2abd0487e818628db589d31f630ca4d894b | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.36e-05 | 196 | 88 | 5 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | Severe-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.36e-05 | 196 | 88 | 5 | ee991f1d9936c656f4fbc2e0cec9e0166a34bc5b | |
| ToppCell | Mild/Remission-Plasmablast|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.36e-05 | 196 | 88 | 5 | dcf0a804a79a05454658498d1f87320c7e079219 | |
| ToppCell | Severe-Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.46e-05 | 197 | 88 | 5 | 1089aa7991812378668d0f3d57f8000e6245a713 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.46e-05 | 197 | 88 | 5 | 1e63879633f20646e44873ae6b662f6faf4806fd | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.46e-05 | 197 | 88 | 5 | f7eaac1c321710a55e09ffb047a7db2baf7b7e28 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.46e-05 | 197 | 88 | 5 | 99fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Others-HSPC|COVID-19_Convalescent / Disease, condition lineage and cell class | 4.46e-05 | 197 | 88 | 5 | c1033a1a8b8b5c8569130aa9405a6e8e65ef7bd0 | |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.46e-05 | 197 | 88 | 5 | fdbf4eb9fa5aefb4ffb307494fe4774bf5e0aaeb | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.57e-05 | 198 | 88 | 5 | 85881637641d8996be2edc65c4bceff0433135e7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.57e-05 | 198 | 88 | 5 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.57e-05 | 198 | 88 | 5 | 732a43061d75bc5e1cf23f5056b72cd10c926668 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-cortical_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.57e-05 | 198 | 88 | 5 | d81f35c0066558ff96dd06f58fca72cd82e681e8 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.57e-05 | 198 | 88 | 5 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-Plasmablast|COVID-19_Severe / Disease, condition lineage and cell class | 4.68e-05 | 199 | 88 | 5 | e6422b65e22e5aa8dfaebdae5be76dd78b978604 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.79e-05 | 200 | 88 | 5 | 107a0665fb20247511a430178effd7630a619488 | |
| ToppCell | control-Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.79e-05 | 200 | 88 | 5 | 251ca08fab5cc2a4e280db6a6286a9ebaef3e61a | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 4.79e-05 | 200 | 88 | 5 | bffebc281a5c1c2bfdb2696a45343787289fc374 | |
| ToppCell | (2)_B_cell-(21)_B_cell_IgG_Plasma|(2)_B_cell / shred on Cell_type and subtype | 4.79e-05 | 200 | 88 | 5 | 2831060d52b210f8927527810611735a99b61999 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.79e-05 | 200 | 88 | 5 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | (21)_B_cell_IgG_Plasma|World / shred on Cell_type and subtype | 5.15e-05 | 203 | 88 | 5 | 15055e1b1017afbdb2a567972cbb976deb7d4e6a | |
| ToppCell | Hippocampus-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.14e-04 | 126 | 88 | 4 | b0bc61be1d4ce8114077c524fedfdf89128bcf12 | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal-Cervical_normal_tissue-Cervical_normal_tissue|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.62e-04 | 138 | 88 | 4 | d3d16b043024914475a5e3db0803be0d4678c165 | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal-Cervical_normal_tissue-Cervical_normal_tissue-5|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.62e-04 | 138 | 88 | 4 | d1efb4ef05aba89dd46ce698c5ce359fe8ab41c1 | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.62e-04 | 138 | 88 | 4 | 3bb5d4c23335866d41e8e99db0676ee5799e5aff | |
| ToppCell | TCGA-Cervix-Solid_Tissue_Normal-Cervical_normal_tissue|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.62e-04 | 138 | 88 | 4 | c4f6381977d39ad3f7e1e1fa1217a802e8804132 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.66e-04 | 139 | 88 | 4 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.52e-04 | 155 | 88 | 4 | 03fd443740272dcb547e39deaf7ae89b8307f241 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-04 | 156 | 88 | 4 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-04 | 156 | 88 | 4 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.71e-04 | 158 | 88 | 4 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.78e-04 | 159 | 88 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 159 | 88 | 4 | cfb4a8c8aac34b1a857956d98382d487abcf5444 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.78e-04 | 159 | 88 | 4 | 204e5a675f4684c9570c24c8d34bbf632fd8164a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 159 | 88 | 4 | a75ab494959575143cefdaec99e7aee3f318d559 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW12-Neuronal-Neurons|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 2.89e-04 | 65 | 88 | 3 | 3c094b098edc216b0bb23a5cbce7950e27713782 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.89e-04 | 65 | 88 | 3 | 4382d56d5f71c7acfe35f84db7257aba2a7dd36a | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.89e-04 | 65 | 88 | 3 | 05b712f83d88e864747cd0229a39aca17321e0f8 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-04 | 162 | 88 | 4 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.06e-04 | 163 | 88 | 4 | d7057ae155058a13f3d7c3db5c7fbc3bb2b69376 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.06e-04 | 163 | 88 | 4 | 240d9f0ea45e8b2c7173e7674fd740555810f9e7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.06e-04 | 163 | 88 | 4 | 55fd4f21c7a8bea031fb6f7f2c8cc1ff42b00d79 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.16e-04 | 67 | 88 | 3 | e53dfc288c943656a0b064afe593ea2101d75437 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.16e-04 | 67 | 88 | 3 | 1841cee311a4b1b802c9e872793435afb730592f | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.27e-04 | 166 | 88 | 4 | f416d8a322f086c769659a9fab6b460a2d546ab1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.27e-04 | 166 | 88 | 4 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| Disease | waist-hip ratio | BPTF APPBP2 BMPR1B IGF2BP2 ANKRD19P PTPRG CNTN5 ANKRD28 C1QTNF7 OLFM2 CPED1 PDZRN4 | 1.59e-04 | 1226 | 83 | 12 | EFO_0004343 |
| Disease | lifestyle measurement, maximum cigarettes per day measurement | 3.97e-04 | 122 | 83 | 4 | EFO_0009264, EFO_0010724 | |
| Disease | total brain volume change measurement | 6.96e-04 | 14 | 83 | 2 | EFO_0021504 | |
| Disease | Eye Abnormalities | 1.03e-03 | 17 | 83 | 2 | C0015393 | |
| Disease | age at menarche | 1.43e-03 | 594 | 83 | 7 | EFO_0004703 | |
| Disease | Autism Spectrum Disorders | 1.80e-03 | 85 | 83 | 3 | C1510586 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.07e-03 | 24 | 83 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | Bone Diseases, Developmental | 2.62e-03 | 27 | 83 | 2 | C0005941 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKHSDYINANYVDGY | 901 | P23470 | |
| TYEEAKAHSQYYAAQ | 106 | Q9Y2J4 | |
| DIYGNTALHYAVYNK | 131 | Q8IVF6 | |
| QDKHYGYNSYSVSNS | 221 | P07858 | |
| YSDFLLYKSGVYQHV | 256 | P07858 | |
| YHNVNGGKTLISYSY | 806 | A4D0V7 | |
| SNQVYCVTDYHKNYA | 446 | Q96IF1 | |
| GATYVLYHDALQNYT | 116 | Q96PS8 | |
| RDKQGYNAVHYSAAY | 501 | O15084 | |
| VYNNSLYYHKGGSNT | 376 | Q6ZMI3 | |
| EYSINNTGKADQTYY | 1021 | O60706 | |
| NKHYIEYSFYLGNHE | 341 | Q9Y5C1 | |
| LAYSSYVHQYSSGKF | 336 | Q92624 | |
| GKYRVYHNQYSTNSF | 846 | Q12830 | |
| YHENGSLYDYLKSTT | 281 | O00238 | |
| YYSNFISHLANIKYP | 176 | P23280 | |
| AHSNQKSAAGYPDYY | 396 | O14646 | |
| DIYSNTALHYAVYNK | 131 | Q9H560 | |
| YYSPINLYHSSDAFK | 76 | O94779 | |
| ETLHYQNLAKYQHYG | 301 | Q7Z5J4 | |
| SYNDYLRAAQMHSGY | 651 | Q96PK6 | |
| KIRNHGEYDLYYSSS | 636 | Q6ZMN7 | |
| HVVYNGSLFYNKYQS | 271 | O95897 | |
| HRIKLGDSSNYYYIS | 406 | Q96QF0 | |
| GAFHNKYYQSIYDTA | 446 | Q92542 | |
| YGNTALHYAIYNEDK | 201 | H3BUK9 | |
| TVYHYNGLKQSNYNE | 381 | Q9H8M7 | |
| FNSTYKLYTHSYLGF | 231 | O75356 | |
| SQLGNAYFYLHDYAK | 66 | P81274 | |
| YFSTGLTEKANHYYK | 266 | Q5TA45 | |
| YYSKNHSYHVEGNLV | 131 | O43451 | |
| DNYSYRGFYQKTHIS | 211 | O75752 | |
| AQYSYLGYAVAVLHK | 456 | P38570 | |
| GTKVHYAYQTNASTY | 421 | Q99784 | |
| SSVYRNGTDIIYNYH | 1936 | Q5H8C1 | |
| YQYATQHGEYDTLNK | 16 | Q86YZ3 | |
| YSHLVSVGYDYHQAK | 41 | Q13401 | |
| LYKYHSQYHTVAGND | 521 | P42356 | |
| NHYTTVLAYNLNYAT | 1681 | P09848 | |
| SGHQFENYSFKISYI | 141 | Q9Y6M1 | |
| YDLSSKYYQTIGNHA | 156 | Q9UNM6 | |
| KYYQTIGNHASYYKD | 161 | Q9UNM6 | |
| YNVYTHSFLCYGKDQ | 246 | P49961 | |
| KVDYNRLGYTHLYSS | 391 | P39656 | |
| ASKYYPLVAQHYASL | 911 | Q9UG01 | |
| SADAKVYSGYYHLDQ | 931 | Q2VWP7 | |
| AYQTGKDISTNYYAS | 666 | P14625 | |
| YLKYHYNASLLDGTL | 391 | O95302 | |
| SNLAYSFYSHKLYAE | 461 | Q14674 | |
| EAYASKSNNTAYLIY | 96 | Q8WZ79 | |
| SQRDYTQYYDHISKQ | 191 | O75794 | |
| EYTGSDYQYVGKLHS | 66 | Q9Y6N8 | |
| SYSYDLSHSLQYNLT | 166 | Q92562 | |
| VYHYRINTASDGKLY | 171 | P00519 | |
| LNNTYIFYTSDNGYH | 316 | P15586 | |
| YTGSDYQYVGKLHSD | 66 | P55285 | |
| GANAKSYYQSSVQYL | 776 | Q86Y56 | |
| AVQYDNHYTNTKYCL | 271 | Q9NX74 | |
| HTFNQQSKDYYAYRL | 56 | Q9H4G1 | |
| KANYSLQIYPDESHY | 811 | P42658 | |
| DGSKITYIDYYRQQH | 351 | Q7Z3Z3 | |
| KQVAQASHSYRVYYN | 196 | O43819 | |
| GIYYFSYDITLANKH | 191 | Q9BXJ2 | |
| VTNSHLTGAKVYYSY | 406 | Q96PB7 | |
| QAYTYLHSSLSKYEA | 186 | A6NGG8 | |
| RYLLNYYSDSDKHQG | 66 | A0A075B6I7 | |
| KAYHNSPAYLAYINA | 131 | Q969G3 | |
| TAYNSYKDGDYNAAV | 561 | Q9UBV2 | |
| YQTAATHYSIAANKY | 571 | Q5TEA6 | |
| YGNTALHYAIYNEDK | 201 | A0A0A6YYL3 | |
| AKQYLSYETLYANGS | 81 | O95084 | |
| SHSYTINGLKKYTEY | 591 | Q92859 | |
| YGNTTLHYAIYNEDK | 201 | P0CG39 | |
| YNFSDLKSPLHYYGN | 281 | Q9Y274 | |
| LQNSSYNHFAAIYYL | 326 | A0A0B4J2F2 | |
| LQNSSYNHFAAIYYL | 326 | P57059 | |
| YKTNLGHHLQYFYSD | 2311 | Q9NT68 | |
| YNHSNSEITSLYYDL | 2336 | Q9NT68 | |
| YQTLYKHHYQAGESL | 781 | Q6UXD5 | |
| ELEKSGYYTLYHSLH | 1961 | Q9ULL5 | |
| RKFYTSSTHYYGQET | 1131 | Q9NZP6 | |
| GKVSNLQYLHSYLTY | 371 | Q9UHB9 | |
| QYSYHDINVYSLAGL | 1356 | A5YKK6 | |
| KYNYHLDSSGSYVFE | 486 | P49588 | |
| ADGKTYYYNNRTLES | 441 | O14776 | |
| VNASYTDSYYKGQTA | 191 | Q8NER1 | |
| SSYHIINADAKYPGY | 6 | Q9NPI9 | |
| TYTSLYKSAYLHPQQ | 336 | Q12899 | |
| NKLTYSHGNYLFHYI | 41 | P51809 | |
| IKHNSDLIYYQGNYV | 216 | Q8N859 | |
| GSSAKNYFHYNQSYP | 311 | P38571 | |
| YKNLQHHDYSTYTFL | 71 | P56181 |